Business Development

Histogen has a strong commitment to the development of first in class and best in class product applications within various therapeutic and aesthetic areas. As an innovator and a supplier of novel hypoxic- induced biomaterials, we seek (i) to leverage the Company’s core competencies in order to develop products within the field of regenerative medicine, and (ii) to supply partners with our proprietary biomaterials to be incorporated into a broader array of products. In support of this mission, Histogen has made a significant investment in its core team of scientists and engineers, its intellectual property portfolio, and its manufacturing infrastructure.

Histogen’s technology platform produces a multipotent cell conditioned media as well as an extracellular matrix material containing cell-signaling proteins which stimulate stem cells in the body to regenerate tissue. These materials have potential to address what Histogen believes are a number of high value aesthetic applications such as hair growth, skin care and soft tissue fillers. In addition, Histogen believes that these materials hold promise in therapeutic applications including orthopedics and wound healing. Working closely with industry-leading partners and collaborators, Histogen looks to maximize the potential of its proprietary technology platform.

For more information about partnering with Histogen, or to arrange a technology presentation, please contact us at or 858.526.3100.

Value Drivers

Value Drivers

Histogen is a regenerative medicine company focused on development of innovative products manufactured by hypoxia-induced multipotent stem cells.

Diverse pipeline of product candidates that can be applied to multiple indications, including product candidates that require no third-party reimbursement

Strong patent portfolio

Treatments without the use of embryonic stem cells or animal products